title: Treatment of cutaneous larva migrans and Toxocara infection.
abstract: The treatment of cutaneous larva migrans and Toxocara infection relies on antihelminthic agents such as thiabendazole, albendazole and ivermectin. The efficacy of these agents varies according to the helminthic disease.
authors.affiliation: Service des Maladies Infectieuses et Tropicales, Hôpital Pitié-Salpêtrière, 47/83 Bld de l'Hôpital, 75651 Paris Cedex 13, France. eric.caumes@psl.ap-hop-paris.fr
authors.forename: Eric
authors.initials: E
authors.lastname: Caumes
mesh_terms: D015766:Albendazole / Q000008:administration & dosage / Q000627:therapeutic use; D000969:Antinematodal Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D004334:Drug Administration Schedule; D006801:Humans; D007559:Ivermectin / Q000008:administration & dosage / Q000627:therapeutic use; D007815:Larva Migrans / Q000188:drug therapy*; D013827:Thiabendazole / Q000008:administration & dosage / Q000627:therapeutic use; D014120:Toxocariasis / Q000188:drug therapy*
chemical_list: D000969:Antinematodal Agents; D007559:Ivermectin; D015766:Albendazole; D013827:Thiabendazole